🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementIs this normal?? My stomach is making SOUNDS — 6 month update

Is this normal?? My stomach is making SOUNDS — 6 month update

Dr.EM_Chicago Sun, Oct 12, 2025 at 10:12 AM 10 replies 1,243 viewsPage 1 of 2
This thread is more than 7 months old. Information may be outdated. Consider searching for more recent discussions.
Dr.EM_Chicago
Member
567
2,567
May 2024
Chicago, IL
Oct 12, 2025 at 10:12 AM#1

The nausea I get is not really nausea, it is an aversion. Food I want in the abstract becomes repellent in front of me, which no side-effect list describes.

What I am after is what distinguishes the nausea you can titrate through from the nausea that means stop.

Practical detail welcome, however dull — the duller the better.

17 12jim_asheville, matt_MKE, Dr.ReproEndo and 14 others
Reply Quote Save Share Report
BariatricNurseD
Senior Member
1,678
7,234
Feb 2024
Dallas, TX
Online
Oct 12, 2025 at 10:37 AM#2

This one has a reasonably settled answer, so here it is. Holding genuinely reduces total burden rather than redistributing it, because the gastric-emptying component adapts. Receptor-level tachyphylaxis to the delayed-emptying effect develops over weeks while the central appetite effect persists, so the same dose is materially more comfortable at week six than at week two. A slower ladder therefore reaches the same dose with less cumulative nausea, not the same nausea spread thinner.

16 11roxy_nash, tony_orlando, Dr.NephBHM_UK and 13 others
Reply Quote Save Share Report
hans_munich
Member
534
2,345
Jul 2024
Munich, DE
Oct 12, 2025 at 11:02 AM#3
BariatricNurseD said:
Holding genuinely reduces total burden rather than redistributing it, because the gastric-emptying component adapts.

No disagreement with BariatricNurseD. One condition attached. The meal advice is right and incomplete without the hydration point. People stop drinking because drinking makes them feel full, then attribute dehydration symptoms to the drug.

Last edited: Oct 12, 2025 at 5:02 PM
15 10Dr.LipidDallas, alex_tucson, kevin_tulsa and 12 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
sarah_TO
Member
278
1,234
Sep 2024
Toronto, CA
Oct 12, 2025 at 11:27 AM#4
Dr.EM_Chicago said:
The nausea I get is not really nausea, it is an aversion.

Can confirm the pattern Dr.EM_Chicago describes. The line between titrate-through and stop is not severity, it is trajectory and what else is present. Nausea that peaks and improves within a week is the expected pattern. Nausea that is escalating, or that comes with severe upper-abdominal pain radiating to the back, or that prevents fluids for more than a day, is a different conversation and belongs with a clinician the same day.

Last edited: Oct 12, 2025 at 3:27 PM
14 9carl_compliance, DanielChem_CHI, marco_milano and 11 others
Reply Quote Save Share Report
GenomicsKate
Member
345
1,890
Oct 2024
Cambridge, MA
Oct 12, 2025 at 1:45 PM#5

From the other side of the consultation, briefly. Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third retelling.

Happy to go further on any of that.

Last edited: Oct 12, 2025 at 6:45 PM
13 8claudia_zurich, nancy_portland, rick_sfbay and 10 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register